Teva Pharmaceuticals is trading 4.1% down at ILA 10,430 as investors take profits following last week’s sharp earnings-driven rally.
- Shares recently surged following upbeat quarterly results and an upward revision to the company's 2026 revenue guidance.
- With no fresh negative company news reported, today’s move appears to reflect normal volatility and short-term profit-taking rather than a shift in underlying fundamentals.